Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lentinula edodes, commonly known as shiitake mushroom, has been studied for various health benefits, including potential effects on bone health and osteoporosis. The justification for its use in osteoporosis is primarily based on emerging scientific evidence rather than traditional application; shiitake mushrooms are not widely referenced in traditional medicine specifically for osteoporosis, though they are used broadly for vitality and immune support in East Asian cultures.

Scientific interest centers around several bioactive components of Lentinula edodes mycelia, such as ergothioneine, polysaccharides, and vitamin D₂. In preclinical (animal and in vitro) studies, extracts from shiitake mycelia have demonstrated the ability to promote osteoblast differentiation and inhibit osteoclast activity, which are key processes in maintaining bone density and reducing bone resorption. For example, a 2019 study found that L. edodes mycelium extract could enhance bone formation in ovariectomized rats, a common model of postmenopausal osteoporosis. Furthermore, shiitake’s capacity to produce vitamin D₂ when exposed to UV light may contribute to improved calcium absorption and bone health.

However, there is a lack of robust clinical trials in humans directly linking Lentinula edodes mycelia supplementation to the prevention or treatment of osteoporosis. The current evidence is preliminary and mostly limited to animal models or cell culture studies. Therefore, while the scientific rationale is plausible and initial results are promising, the strength of evidence remains modest (rated 2/5), and further human studies are needed to confirm efficacy and safety for osteoporosis support.

More about Lentinula edodes mycelia
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by Lentinula edodes mycelia

Products containing Lentinula edodes mycelia